Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Genetic Disease | Family Medicine
Disease Category: Bipolar Disorder
Location: United States, TX

Clinical Trial Details

Overview

Research Study Summary

Bipolar Depression study with 6-month open-label therapy

Purpose

If you or someone you know suffers from bipolar depression, you may be eligible to participate in a research medication study. This study consists of 8 weeks followed by 6 months of open-label therapy. Qualified participants are eligible to receive the following at no cost: study medication, medical and psychiatric assessments, lab work and sessions with a physician and/or a clinical study coordinator.

Patient Inclusion/Exclusion Criteria:

  • Males and females 18 years and older.
  • Subjects must be diagnosed with bipolar depression
  • Must have experienced at least one previous manic or mixed episode
  • Subjects must not have any serious, unstable illnesses or have substance dependence within the past 30 days.
To Learn more
Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Carol Shreve
Bayou City Research Corporation
550 Westcott
Suite 310
Houston, TX 77007
Phone: 832-251-7000
Fax: 832-251-7011

View Map

Research Center Information: Bayou City Research Corporation

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 25374

Date Last Changed: July 25, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.